Compound Summary
Compound Name: | ISOGUVACINE HYDROCHLORIDE |
Compound CID: | 155107 |
Synonyms: | ISOGUVACINE HYDROCHLORIDE 68547-97-7 1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid hydrochloride Isoguvacine (hydrochloride) 1,2,3,6-tetrahydropyridine-4-carboxylic acid hydrochloride More... |
Iupac Name: | 1,2,3,6-tetrahydropyridine-4-carboxylic acid;hydrochloride |
InChI: | InChI=1S/C6H9NO2.ClH/c8-6(9)5-1-3-7-4-2-5;/h1,7H,2-4H2,(H,8,9);1H |
InChIKey: | SUWREQRNTXCCBL-UHFFFAOYSA-N |
Canonical Smiles: | C1CNCC=C1C(=O)O.Cl |
Isomeric Smiles: | C1CNCC=C1C(=O)O.Cl |
Molecular Weight: | 163.6 |
Molecular Formula: | C6H10ClNO2 |
Molecular Weight: | 163.6 |
Molecular Formula: | C6H10ClNO2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 10 |
Complexity: | 151 |
ISOGUVACINE HYDROCHLORIDE | ISOGUVACINE HYDROCHLORIDE |
---|---|
ISOGUVACINE HYDROCHLORIDE |
68547-97-7 |
1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid hydrochloride |
Isoguvacine (hydrochloride) |
1,2,3,6-tetrahydropyridine-4-carboxylic acid hydrochloride |
4-Pyridinecarboxylic acid, 1,2,3,6-tetrahydro-, hydrochloride |
1,2,3,6-Tetrahydro-pyridine-4-carboxylic acid hydrochloride |
MFCD00055192 |
1,2,3,6-tetrahydropyridine-4-carboxylic acid;hydrochloride |
1,2,3,6-TETRAHYDRO-4-PYRIDINECARBOXYLIC ACID HCL |
SR-01000075611 |
Isoguvacine HCl |
C6H9NO2.HCl |
MLS000859962 |
SPECTRUM1502129 |
CHEMBL540303 |
SCHEMBL7958625 |
Isoguvacine hydrochloride, solid |
1,2,3,6-Tetrahydro-pyridine-4-carboxylic acidhydrochloride |
DTXSID00218663 |
AMY32016 |
Tox21_500561 |
AKOS015847455 |
CCG-221865 |
CS-6967 |
LP00561 |
SB38324 |
NCGC00093946-01 |
NCGC00093946-02 |
NCGC00093946-03 |
NCGC00261246-01 |
AS-31641 |
SMR000326821 |
SY012592 |
HY-100810 |
B6230 |
EU-0100561 |
FT-0670465 |
G-002 |
I-185 |
I0871 |
1,2,5,6-tetrahydroisonicotinic acid hydrochloride |
A867023 |
SR-01000075611-1 |
SR-01000075611-3 |
1,2,3,6-tetrahydropyridine-4-carboxylic acid;hydrochloride. |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 1.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 1.000000000000000 | 1 | 1 |